Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
What Features To Look For In No Annual Fee Cards
Understanding the key features of no annual fee cards can help you maximize benefits. Discover what to prioritize for your financial needs.
18,760 articles
Sells $2.4 Million International: A CEO Insider Move
When a CEO discloses a large stock sale, markets react. This guide breaks down what sells $2.4 million international ...
Ardent Health Stock After Insider Buy: Buy or Not?
A director just bought more than 11,000 Ardent Health shares, sparking questions about the stock after this insider m...
Transportation Stock After Director: Is via a Buy?
A director bought a sizable stake in VIA Transportation, prompting questions about the stock’s future. This guide bre...
Sells 2,622 Shares Fresh Del Monte: What It Means Now
An executive at Fresh Del Monte sold 2,622 shares. This article explains what that means for investors, how to read i...
Director Sells 33,000 Impinj: Insider Move to Watch
A high-profile insider move hits Impinj as a director sells 33,000 impinj shares. Learn what this signals, how to ana...
Septerna's Chief People Officer Stock Move: Investor View
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
Spacex Stock Down From High After Nasdaq-100: Is It a Buy?
SpaceX joined the Nasdaq-100 with high expectations, but the first day brought a meaningful pullback. This guide brea...
York Just Banned Data: What It Means for Microsoft, Amazon, and Google
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
What This MannKind Director Signals Risk to Royalties
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
Coeur Mining (CDE) 2025 Earnings Outlook and Q4 Review
Investors are weighing how Coeur Mining performed in Q4 2025 and what it means for coeur mining (cde) 2025. This view...
Biotech Fund Dumps Million: What It Signals for Investors
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status